Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

REvascularisation for Heart Failure With PReserved Ejection Fraction and Ischaemia: EValuation of Efficacy and Mechanistic Description

NCT07560436 is registered in ClinicalTrials.gov with King's College London as lead sponsor.

NCT NCT07560436
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07560436 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
REvascularisation for Heart Failure With PReserved Ejection Fraction and Ischaemia: EValuation of Efficacy and Mechanistic Description
Lead sponsor
King's College London
Phase
Phase 2
Overall status
Recruiting
Start date
March 23, 2026
Completion date
August 31, 2029
Enrollment
350 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

coronary artery disease, heart failure with preserved ejection fraction (hfpef)